INO vs SCHW · $88.0M cap vs P/E 19, rev $13.55B
Inovio Pharmaceuticals Inc (INO) versus Charles Schwab Corp (SCHW) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
INO currently screens at market cap $88.0M. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Not investment advice. Open the INO and SCHW stock pages for the full models.
Not investment advice.